# Tandem Programme – Translational research collaboration between Basic and Clinical Researchers

**Funder:** Novo Nordisk Foundation
**Budget:** Up to DKK 13 mio. per grant
**Duration:** 4 years
**Consortium:** Required — 1 basic researcher + 1 clinical researcher (co-applicant may be based abroad)
**Frequency:** Annual
**Next round:** 2026-10
**Eligible countries:** DK
**Official call:** https://novonordiskfonden.dk/en/grant/tandem-programme-translational-research-collaboration-between-basic-and-clinical-researchers/
**Last verified:** 20 June 2026

## Eligibility & scope

Supports Danish translational health research collaborations between one basic and one clinical researcher. Project must be anchored at a university, hospital, or non-profit research institution in Denmark; main applicant must have primary employment in Denmark (≥75%). Co-applicant may be based abroad. Focus areas: bioscience, basic biomedicine, clinical and translational medicine.

## Summary

The Tandem Programme funds translational research collaborations in Denmark between one basic and one clinical researcher, with up to DKK 13 million per project over four years. The call targets bioscience, basic biomedicine, and clinical/translational medicine projects where the main applicant holds ≥75% primary employment in Denmark, while the co-applicant may be based abroad. This is an annual programme emphasizing the bridge between bench and bedside research.

## Who should apply

- Main applicant with ≥75% primary employment at a Danish university, hospital, or non-profit research institution
- Basic and clinical researcher pairs (co-applicant may be abroad)
- Projects bridging bench science and clinical application in bioscience, biomedicine, or translational medicine
- Established researchers with a track record of collaborative translational work

## Key dates

- Next deadline expected October 2026 (verify exact date on Novo Nordisk Foundation website)
- Four-year project duration
- Annual call frequency

## Tips for applicants

- The consortium is mandatory and gating: a single-investigator proposal will not be reviewed. Ensure your co-applicant has a named role and commitment letter before submission.
- Reviewers prioritise concrete translational pathways, not just co-location of basic and clinical labs. Make the mechanistic link and clinical relevance explicit in your proposal narrative.
- The main applicant's Danish employment threshold is strictly enforced at ≥75%; document this clearly in your institutional letter.

## Frequently asked questions

### How much funding does the Tandem Programme provide?

Up to DKK 13 million per project over four years.

### Who is eligible to be the main applicant for the Tandem Programme?

A researcher with ≥75% primary employment at a Danish university, hospital, or non-profit research institution.

### Can my co-applicant be based outside Denmark?

Yes, the co-applicant (clinical or basic researcher) may be based abroad, but the main applicant must be Denmark-based.

### When is the next Tandem Programme deadline?

The next call is expected in October 2026; verify the exact date on the Novo Nordisk Foundation website.

---

Source: [The Great Grantsby](https://grantsby.eu/grants/novo-nordisk-foundation-tandem-programme-translational-research-collaborat-2026) — EU grant monitoring for academic researchers. Always verify details on the funder's website before applying.

**See which EU calls match your profile.** [Preview your matches in 30 seconds, no signup](https://grantsby.eu/demo?ref=llm_grant_md).